Dr Jackie Elliott

All publications

Journal articles

• Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA , Saraf S et al (2023) Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study. Diabetes Care, 46(10), 1831-1838.
• Holman N, Woch E, Dayan C, Warner J, Robinson H, Young B & Elliott J (2023) National Trends in Hyperglycemia and Diabetic Ketoacidosis in Children, Adolescents, and Young Adults With Type 1 Diabetes: A Challenge Due to Age or Stage of Development, or Is New Thinking About Service Provision Needed?. Diabetes Care, 46(7), 1404-1408.
• Khadem H, Nemat H, Elliott J & Benaissa M (2023) Blood glucose level time series forecasting: nested deep ensemble learning lag fusion. Bioengineering, 10(4). View this article in WRRO
• Nemat H, Khadem H, Elliott J & Benaissa M (2023) Causality analysis in type 1 diabetes mellitus with application to blood glucose level prediction. Computers in Biology and Medicine, 153, 106535-106535.
• Khadem H, Nemat H, Elliott J & Benaissa M (2022) Interpretable machine learning for inpatient COVID-19 mortality risk assessments: diabetes mellitus exclusive interplay. Sensors, 22(22). View this article in WRRO
• Khadem H, Nemat H, Elliott J & Benaissa M (2022) Signal fragmentation based feature vector generation in a model agnostic framework with application to glucose quantification using absorption spectroscopy. Talanta, 243. View this article in WRRO
• Khadem H, Nemat H, Eissa MR, Elliott J & Benaissa M (2022) COVID-19 mortality risk assessments for individuals with and without diabetes mellitus : machine learning models integrated with interpretation framework. Computers in Biology and Medicine, 144. View this article in WRRO
• Sathyanarayanan A, Crabtree T, Choudhary P, Elliott J, Evans ML, Lumb A & Wilmot EG (2022) Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic. Diabetes Research and Clinical Practice, 185, 109777-109777.
• Nemat H, Khadem H, Eissa MR, Elliott J & Benaissa M (2022) Blood glucose level prediction : advanced deep-ensemble learning approach. IEEE Journal of Biomedical and Health Informatics. View this article in WRRO
• Iqbal A, Greig M, Arshad MF, Julian TH, Ee Tan S & Elliott J (2021) Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with diabetes : findings from two university hospitals in the U.K.. Diabetes Research and Clinical Practice, 178.
• CRABTREE TSJ, ELLIOTT J, BICKERTON A, GALLEN IW, DHATARIYA K, CULL ML, EVANS A, PHILLIPS SM & RYDER RE (2021) 803-P: The Association between Empagliflozin and Changes in Alanine Aminotransferase Levels: Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme. Diabetes, 70(Supplement_1).
• Stanton‐Fay SH, Hamilton K, Chadwick PM, Lorencatto F, Gianfrancesco C, de Zoysa N, Coates E, Cooke D, McBain H, Heller SR & Michie S (2021) The DAFNEplus programme for sustained type 1 diabetes self-management: Intervention development using the Behaviour Change Wheel. Diabetic Medicine, 38(5). View this article in WRRO
• Coates E, Amiel S, Baird W, Benaissa M, Brennan A, Campbell M, Chadwick P, Chater T, Choudhary P, Cooke D , Cooper C et al (2021) Protocol for a cluster randomised controlled trial of the DAFNEplus (Dose Adjustment for Normal Eating) intervention compared with 5x1 DAFNE : a lifelong approach to promote effective self-management in adults with type 1 diabetes. BMJ Open, 11(1). View this article in WRRO
• Carlton J, Rowen D & Elliott J (2020) Assessment of the psychometric properties and refinement of the health and self-management in diabetes questionnaire (HASMID). Health and Quality of Life Outcomes, 18(1). View this article in WRRO
• Heller SR, Gianfrancesco C, Taylor C & Elliott J (2020) What are the characteristics of the best type 1 diabetes patient education programmes (from diagnosis to long‐term care), do they improve outcomes and what is required to make them more effective?. Diabetic Medicine, 37(4), 545-554.
• Zaitcev A, Eissa MR, Hui Z, Good T, Elliott J & Benaissa M (2020) A deep neural network application for improved prediction of HbA1c in type 1 diabetes. IEEE Journal of Biomedical and Health Informatics. View this article in WRRO
• Johnson B, Norman P, Sanders T, Elliott J, Whitehead V, Campbell F, Hammond P, Ajjan R & Heller S (2019) Working with insulin, carbohydrates, ketones and exercise to manage diabetes (WICKED) : evaluation of a self‐management course for young people with Type 1 diabetes. Diabetic Medicine. View this article in WRRO
• Rowen D, Carlton J & Elliott J (2019) PROM validation using paper-based or online surveys : data collection methods affect the sociodemographic and health profile of the sample. Value in Health, 22(8), 845-850. View this article in WRRO
• Shillo P, Sloan G, Greig M, Hunt L, Selvarajah D, Elliott J, Gandhi R, Wilkinson ID & Tesfaye S (2019) Painful and Painless Diabetic Neuropathies: What Is the Difference?. Current Diabetes Reports, 19. View this article in WRRO
• Sanders T, Elliott J, Norman P, Johnson B & Heller S (2019) Disruptive illness contexts and liminality in the accounts of young people with type 1 diabetes. Sociology of Health & Illness, 41(7), 1289-1304.
• Pang T, Bain SC, Black RNA, Boyle JG, Elliott J, Holcombe A, Lee KCS, Mulligan C, Saunders L, Yousseif A & Baxter M (2019) A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA). Diabetic Medicine, 36(1), 110-119.
• Campbell F, Lawton J, Rankin D, Clowes M, Coates E, Heller S, De Zoysa N, Elliott J & Breckenridge J (2018) Follow-Up Support for Effective type 1 Diabetes self-management (The FUSED Model): A systematic review and meta-ethnography of the barriers, facilitators and recommendations for sustaining self-management skills after attending a structured education programme. BMC Health Services Research, 18. View this article in WRRO
• Sanders T, Elliott J, Norman P, Johnson B & Heller S (2018) Experiences of self-management among young adults with type 1 diabetes in the context of a structured education programme: a qualitative study. Diabetic Medicine, 35(11), 1531-1537. View this article in WRRO
• Rowen DL, Labeit A, Stevens K, Elliot J, Mulhern B, Carlton J, Basarir H & Brazier J (2018) Estimating a preference-based single index measuring the quality of life impact of self-management for diabetes. Medical Decision Making, 38(6), 699-707. View this article in WRRO
• Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H & White D (2018) Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open, 8(4). View this article in WRRO
• Rowen DL, Stevens K, Labeit A, Elliott J, Mulhern B, Carlton J, Basarir H, Ratcliffe J & Brazier J (2018) Using a Discrete Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Value in Health, 21(1), 69-77. View this article in WRRO
• Mulhern B, Labeit A, Rowen DL, Knowles E, Meadows K, Elliott J & Brazier J (2017) Developing preference-based measures for diabetes: DHP-3D and DHP-5D. Diabetic Medicine, 34(9), 1264-1275. View this article in WRRO
• Carlton J, Elliott J, Rowen D, Stevens K, Basarir H, Meadows K & Brazier J (2017) Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voice. Health and Quality of Life Outcomes, 15. View this article in WRRO
• Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, Beckwith A, Brennan A , Campbell M et al (2017) A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Health Technology Assessment, 21(20), 1-278. View this article in WRRO
• Heller S, Amiel S, Campbell M, Choudhary P, Cooper C, Dimairo M, Elliott J, Hammond P, Lee E, Lindsay R , Waugh N et al (2017) Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ, 356. View this article in WRRO
• Lawton J, White D, Rankin D, Elliott J, Taylor C, Cooper C, Heller S & Hallowell N (2017) Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study. Trials, 18. View this article in WRRO
• Bentley CL, Otesile O, Bacigalupo R, Elliott J, Noble H, Hawley MS, Williams EA & Cudd P (2016) Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes. BMC Medical Informatics and Decision Making, 16(1), 92-92. View this article in WRRO
• Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H & Kruger J (2016) The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes. Medical Decision Making, 36(8), 1020-1033. View this article in WRRO
• Lawton J, Kirkham J, Rankin D, White DA, Elliott J, Jaap A, Smithson WH, Heller S, Gianfrancesco C, Gordon V , Greaves L et al (2016) Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial. Diabetic Medicine, 33(2), 243-251.
• Mungreiphy NK, Mamza J, Lakhdar AF, Bannister M, Elliott J & Idris I (2015) Clinical use and efficacy of biphasic insulin lispro 50/50 in people with insulin treated diabetes – a nationwide evaluation of clinical practice. Current Medical Research and Opinion, 31(3), 493-501. View this article in WRRO
• Elliott J, Rankin D, Jacques RM, Lawton J, Emery CJ, Campbell MJ, Dixon S & Heller SR (2015) A cluster randomized controlled non-inferiority trial of 5-day Dose Adjustment for Normal Eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: the DAFNE 5 × 1-day trial. Diabetic Medicine, 32(3), 391-398. View this article in WRRO
• Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S & Elliott J (2014) Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: A longitudinal qualitative investigation. Diabetes Research and Clinical Practice, 106(3), 443-450. View this article in WRRO
• White D, Waugh N, Elliott J, Lawton J, Barnard K, Campbell MJ, Dixon S & Heller S (2014) The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial. BMJ Open, 4(9), e006204-e006204. View this article in WRRO
• Elliott J, Jacques RM, Kruger J, Campbell MJ, Amiel SA, Mansell P, Speight J, Brennan A & Heller SR (2014) Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes.. Diabet Med, 31(7), 847-853. View this article in WRRO
• Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J & Heller S (2014) Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model.. Diabet Med, 31(4), 477-486.
• Elliott J, Beveridge S, Gordon V, James C, Dodd T & Scott A (2014) Diabetes patients requiring ambulance assistance for severe hypoglycaemia have twice the mortality rate of the general diabetes clinic: identification of possible risk factors. DIABETIC MEDICINE, 31, 26-26.
• De Zoysa N, Stadler M, Britneff E, Choudhary P, Amiel SA, Rogers H, Gianfrancesco C, Beveridge S, Elliott J & Heller S (2014) A psychoeducational program to restore hypoglycemia awareness: The DAFNE-HART pilot study. Diabetes Care, 37(3), 863-866.
• Beer R, Eiser C, Johnson B, Bottrell K, Whitehead V, Elliott J, Gibson C & Heller S (2014) WICKED: The development and evaluation of a psycho-education programme for young people with type 1 diabetes. Journal of Diabetes Nursing, 18(6), 233-237.
• Lawton J, Rankin D, Elliott J, Heller SR, Rogers HA, De Zoysa N, Amiel S & Grp UKNIHRDAFNES (2014) Experiences, Views, and Support Needs of Family Members of People With Hypoglycemia Unawareness: Interview Study. DIABETES CARE, 37(1), 109-115.
• Rankin D, Barnard K, Elliott J, Cooke D, Heller S, Gianfrancesco C, Taylor C & Lawton J (2014) Type 1 diabetes patients' experiences of, and need for, social support after attending a structured education programme: a qualitative longitudinal investigation. Journal of Clinical Nursing, 23(19-20), 2919-2927.
• Elliott J & Rankin D (2014) Hypoglycaemia unawareness: A call not to forget the needs of family members. Diabetes and Primary Care, 16(1), 9.
• Rankin D, Elliott J, Heller S, Amiel S, Rogers H, DeZoysa N & Lawton J (2014) Experiences of hypoglycaemia unawareness amongst people with Type 1 diabetes: A qualitative investigation. Chronic Illness, 10(3), 180-191.
• Johnson B, Elliott J, Scott A, Heller S & Eiser C (2014) Medical and psychological outcomes for young adults with Type 1 diabetes: no improvement despite recent advances in diabetes care.. Diabet Med, 31(2), 227-231.
• Lawton J, Rankin D & Elliott J (2013) Is consulting patients about their health service preferences a useful exercise?. Qualitative Health Research, 23(7), 876-886.
• Grant L, Lawton J, Hopkins D, Elliott J, Lucas S, Clark M, MacLellan I, Davies M, Heller S & Cooke D (2013) Type1 diabetes structured education: what are the core self-management behaviours?. DIABETIC MEDICINE, 30(6), 724-730.
• Eiser C, Johnson B, Brierley S, Young V, Bottrell K, Whitehead V, Elliott J, Scott AR & Heller S (2013) Using the Medical Research Council framework to develop a complex intervention to improve delivery of care for young people with Type 1 diabetes. DIABETIC MEDICINE, 30, 191-191.
• Eiser C, Johnson B, Brierley S, Ayling K, Young V, Bottrell K, Whitehead V, Elliott J, Scott A & Heller S (2013) Using the Medical Research Council framework to develop a complex intervention to improve delivery of care for young people with type 1 diabetes.. Diabet Med, 30(6), e223-e228.
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S (2013) The cost-effectiveness of Dose Adjustment for Normal Eating (DAFNE) structured education in Type 1 diabetes: an update using the Sheffield Type 1 diabetes policy model. DIABETIC MEDICINE, 30, 133-134.
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, Heller S & Speight J (2013) The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. DIABETIC MEDICINE, 30(10), 1236-1244.
• Lawton J, Rankin D, Cooke DD, Elliott J, Amiel S, Heller S & UK NIHR DAFNE Study Group (2013) Self-treating hypoglycaemia: a longitudinal qualitative investigation of the experiences and views of people with Type 1 diabetes.. Diabet Med, 30(2), 209-215.
• Young V, Eiser C, Johnson B, Brierley S, Epton T, Elliott J & Heller S (2013) Eating problems in adolescents with Type 1 diabetes: a systematic review with meta-analysis.. Diabet Med, 30(2), 189-198.
• Young V, Eiser C, Johnson B, Brierley S, Epton T, Elliott J & Heller S (2012) Eating Disorders in Adolescents with Type 1 Diabetes: A systematic review with meta-analysis. PSYCHOLOGY & HEALTH, 27, 142-142.
• Rankin D, Cooke D, Elliott J, Heller S, Lawton J & Amiel S (2012) Supporting self-management after attending a structured education programme: a qualitative longitudinal investigation of type 1 diabetes patients’ experiences and views. BMC Public Health, 12. View this article in WRRO
• Rankin D, Cooke DD, Heller S, Elliott J, Amiel S, Lawton J & UK National Institute for Health Research (NIHR) Dose Adjustment for Normal Eating (DAFNE) Study Group (2012) Experiences of using blood glucose targets when following an intensive insulin regimen: a qualitative longitudinal investigation involving patients with Type 1 diabetes.. Diabet Med, 29(8), 1079-1084.
• Lawton J, Rankin D, Cooke D, Elliott J, Heller S & Amiel S (2012) Patients' experiences of adjusting insulin doses when implementing flexible intensive insulin therapy: A longitudinal, qualitative investigation. Diabetes Research and Clinical Practice.
• Thong KY, Jose B, Sukumar N, Cull ML, Mills AP, Sathyapalan T, Shafiq W, Rigby AS, Walton C & Ryder REJ (2011) Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*. Diabetes, Obesity and Metabolism, 13(8), 703-710.
• Rankin D, Cooke DD, Clark M, Heller S, Elliott J, Lawton J & UK NIHR DAFNE Study Group (2011) How and why do patients with Type 1 diabetes sustain their use of flexible intensive insulin therapy? A qualitative longitudinal investigation of patients' self-management practices following attendance at a Dose Adjustment for Normal Eating (DAFNE) course.. Diabet Med, 28(5), 532-538.
• Lawton J, Rankin D, Cooke DD, Clark M, Elliot J & Heller S (2011) Dose Adjustment for Normal Eating: A qualitative longitudinal exploration of the food and eating practices of type 1 diabetes patients converted to flexible intensive insulin therapy in the UK. Diabetes Research and Clinical Practice, 91(1), 87-93.
• Elliott J, Mackie A, Dibden C, Blumsohn A & Creagh F (2010) Oral quinine-induced hypoglycaemic seizures. Practical Diabetes International, 27(1), 32-33.
• Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, Fuller JH & EURODIAB Prospective Complications Study Group (2009) Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.. Diabetes Care, 32(10), 1896-1900. View this article in WRRO
• Elliott J, Rajbhandari S, Dent M, Plater M, Harris N, Emery C, Ward J & Tesfaye S (2007) Risk factors for diabetic peripheral neuropathy in subjects with good glycaemic control: the role of ankle brachial pressure index. DIABETIC MED, 24, 14-14.
• Elliott J, Connor ME & Lashen H (2003) The value of outpatient hysteroscopy in diagnosing endometrial pathology in postmenopausal women with and without hormone replacement therapy.. Acta Obstet Gynecol Scand, 82(12), 1112-1119.
• Elliott J, Hallsworth J, Sutton MR & Tesfaye S (2002) Multidisciplinary Diabetic Foot Assessment Tool: a quick comprehensive system for the diabetic foot clinic. Practical Diabetes International, 19(5), 139-139.
• Elliott J & Reynolds GP (1999) Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brain.. Eur J Pharmacol, 386(2-3), 313-315.
• Reynolds GP & Elliott J (1999) Human brain 5-HT1a receptors and antipsychotic action: Effects of quetiapine. SCHIZOPHR RES, 36(1-3), 313-313.
• Elliott J, Guo L & Traynor JR (1997) Tolerance to mu-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5'-O-(3-[35S]-thio)triphosphate binding.. Br J Pharmacol, 121(7), 1422-1428.
• Schmidhammer H, Daurer D, Wieser M, Monory K, Borsodi A, Elliott J & Traynor JR (1997) Synthesis and biological evaluation of 14-alkoxymorphinans. 14.1 14-ethoxy-5-methyl substituted indolomorphinans with δ opioid receptor selectivity. Bioorganic & Medicinal Chemistry Letters, 7(2), 151-156.
• Elliott J & Traynor JR (1994) [35S]GTPγS binding in SH-SY5Y human neuroblastoma cells as a model for the study of opioid tolerance. Regulatory Peptides, 54(1), 91-92.
• Paterson SJ, Elliott J & Traynor JR (1994) Binding of the selectiveδ-ligand [3H]-TIPP in guinea-pig brain and NG 108-15 cells. Regulatory Peptides, 54(1), 221-222.
• Elliott J & Traynor JR (1994) Lack of modulation of μ-opioid agonists by δ-opioid agonists in isolated tissue bioassay preparations. Regulatory Peptides, 53, S41-S42.
• Elliott J, Sloan G, Stevens L, Selvarajah D, Cruccu G, Gandhi RA, Kempler P, Fuller JH, Chaturvedi N & Tesfaye S () Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study. Diabetologia.
• Zaitcev A, Eissa MR, Hui Z, Good T, Elliott J & Benaissa M () Corrigendum: Automatic inference of hypoglycemia causes in type 1 diabetes: a feasibility study. Frontiers in Clinical Diabetes and Healthcare, 4.
• Eissa MR, Benaissa M, Good T, Hui Z, Gianfrancesco C, Ferguson C & Elliott J () Analysis of real‐world capillary blood glucose data to help reduce HbA1c and hypoglycaemia in type 1 diabetes: evidence in favour of using percentage of readings in target and coefficient of variation. Diabetic Medicine.
• Heller S, Lawton J, Amiel S, Cooke D, Mansell P, Brennan A, Elliott J, Boote J, Emery C, Baird W , Basarir H et al () Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes. Programme Grants for Applied Research, 2(5), 1-188. View this article in WRRO
• Elliott J, Lawton J, Rankin D, Emery C, Campbell M & Dixon S () The 5x1 DAFNE Study Protocol: A cluster randomised trial comparing a standard 5 day DAFNE course delivered over 1 week against DAFNE training delivered over 1 day a week for 5 consecutive weeks.. BMC Endocrine Disorders. View this article in WRRO
• Elliott J, Smart D, Lambert DG & Traynor JR () Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine. European Journal of Pharmacology, 16, 447-450.
• Traynor J & Elliott J () -Opioid receptor subtypes and cross-talk with -receptors.. Trends in Pharmacological Sciences, 14, 84-86.
• Elliott J & Traynor J () Evidence for a lack of modulation of -opioid agonist action by -opioid agonists in the mouse vas deferens and guinea-pig ileum. British Journal of Pharmacology, 114, 1064-1068.
• Rupniak N, Patel S, Marwood , Marwood R, Webb J, Traynor J, Elliott J, Freedman S , Fletcher S & Hill R () Antinociceptive and toxic effects of (+)epibatidine oxalate attributable to nicotinic agonist activity. British Journal of Pharmacology, 113, 1487-1493.
• Elliott J, Heller S, Hopkinson H & Mansell P () Does duration of type 1 diabetes affect the outcomes of structured education?. Diabetologia.

Conference proceedings papers

• Richardson LS, Woolgar S, Thompson G, Rogers P & Elliott J (2022) Triumph over adversity: Remote Dose Adjustment For Normal Eating (DAFNE). Is remote DAFNE an even more effective intervention for adults with type 1 diabetes than traditional face to face DAFNE education?. DIABETIC MEDICINE, Vol. 39
• Goolam--Mahomed Z, Narendran P, Karamat M, Elliott J, Hedgcock B & Edwards J (2022) Approaches to managing adults with newly diagnosed type 1 diabetes: Results of a national survey. DIABETIC MEDICINE, Vol. 39
• Woolgar S, Richardson L, Hedgcock B, Thompson G & Elliott J (2022) Improving thousands of consultations with people with type 1 diabetes redesign of the Dose Adjustment For Normal Eating (DAFNE) Doctor Programme: The best things in life are free. DIABETIC MEDICINE, Vol. 39
• Elliott J, Woolgar S, Richardson L, Hedgcock B, May J, Wright M & Thompson G (2021) Remote DAFNE passes the 'friends and family' test: 95% of participants would recommend it to someone else with type 1 diabetes. DIABETIC MEDICINE, Vol. 38
• Rogers P, Woolgar S, Richardson L, Hedgcock B, Thompson G & Elliott J (2021) People with type 1 diabetes of Black and minority ethnic origin benefit from attending structured education. DIABETIC MEDICINE, Vol. 38
• Iqbal A, Arshad M, Julian T, Tan S, Greig M & Elliott J (2021) Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital covid-19 mortality in people with diabetes: Findings from two university hospitals in the UK. DIABETIC MEDICINE, Vol. 38
• Crabtree TSJ, Elliott J, Sivappriyan S, Barnes D, Bickerton A, Gallen I, Idris I & Ryder REJ (2021) The impact of sodium glucose link transporter-2 inhibitors (SGLT2i) on Fib4 score in patients with type 2 diabetes: Analysis using Association of British Clinical Diabetologists (ABCD) nationwide audit data. DIABETIC MEDICINE, Vol. 38
• (2020) Clinical care and other categories posters: Education and self‐management. Diabetic Medicine, Vol. 37(S1) (pp 90-118)
• Khadem H, Nemat H, Elliott J & Benaissa M (2020) Multi-lag stacking for blood glucose level prediction. Knowledge Discovery in Healthcare Data 2020, Vol. 2675 (pp 146-150). Santiago de Compostela, Spain (virtual), 29 August 2020 - 30 August 2020. View this article in WRRO
• Nemat H, Khadem H, Elliott J & Benaissa M (2020) Data fusion of activity and CGM for predicting blood glucose levels. Knowledge Discovery in Healthcare Data 2020, Vol. 2675 (pp 120-124). Santiago de Compostela, Spain, 29 August 2020 - 30 August 2020. View this article in WRRO
• Mansell P, Bond R, Pouwer F, Elliott J, Hopkins D, Vallis M, Speight J, Heller S, Lawton J & Cooke D (2020) Assessment of self-care behaviours in adults with type 1 diabetes: Development and validation of the SCB-T1D questionnaire. DIABETIC MEDICINE, Vol. 37 (pp 112-112)
• Binns-Hall O, Selvarajah D, Elliott J, Walker J, Scott A & Tesfaye S (2019) High prevalence of diabetic peripheral neuropathy unmasked by a one-stop microvascular screening service in a hard-to-reach group of young persons with Type 1 diabetes. Diabetic Medicine, Vol. 36 (pp 145-145) View this article in WRRO
• Swift P, Henderson K, Rimmel J, Mitchell S, Francesco G & Elliott J (2019) Modifiable parameters that are associated with improved glycaemic outcomes in patients with Type 1 diabetes using insulin pump therapy. DIABETIC MEDICINE, Vol. 36 (pp 167-167)
• Velikova G, Valderas JM, Potter C, Batchelder L, A’Court C, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder J , Fox D et al (2017) Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Oxford 2017: Advances in Patient Reported Outcomes Research. Health and Quality of Life Outcomes, Vol. 15(S1) View this article in WRRO
• White D, Lawton J, Rankin D, Elliott J, Taylor C, Cooper C, Heller S & Hallowell N (2017) Staff experiences of closing out a clinical trial involving withdrawal of treatment : qualitative study. Trials, Vol. 18(Suppl 1) (pp 91-91). Liverpool, UK, 7 May 2017 - 10 May 2017. View this article in WRRO
• Croudace T, Brazier J, Gutacker N, Street A, Robotham D, Waterman S, Rose D, Satkunanathan S, Wykes T, Nasr N , Enderby P et al (2016) Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research. Health and Quality of Life Outcomes, Vol. 14(Suppl 1), 9 June 2016 - 9 June 2016. View this article in WRRO
• Bagary G, Treble R, Taylor C, Scott A & Elliott J (2016) Is the new Type 1 NICE guidance right? Does basal bolus therapy using analogue insulins from diagnosis in adults with Type 1 diabetes improve outcomes?. DIABETIC MEDICINE, Vol. 33 (pp 188-188)
• Basarir H, Pollard D, Brennan A, Elliott J, Heller S & Campbell MJ (2014) The Potential Value of Ongoing Support In Type-1 Diabetes Mellitus With Dafneplus: Exploratory Pre-Trial Cost-Effectiveness Analysis On Proposed Trial End-Point Target For 12-Month Hba1c Improvement. Value in Health, Vol. 17(7) (pp A350-A350)
• Stadler M, Shuttlewood EM, Rogers H, Gianfrancesco C, Beveridge S, Britneff E, Choudhary P, Elliott J, Rankin AD, Heller SA , Lawton J et al (2014) DAFNE-HART, a psycho-educational programme to reverse hypoglycaemia unawareness in Type 1 diabetes: report on sustained biomedical benefit at 1 year, and the user experience. DIABETIC MEDICINE, Vol. 31 (pp 8-9)
• Dezoysa N, Rogers H, Gianfrancesco C, Beveridge S, Francis V, Elliott J, Choudhary P, Heller S & Amiel SA (2013) A psychological intervention for tackling intractable hypoglycaemia in patients with Type 1 diabetes: the pilot study Dose Adjustment for Normal Eating Hypoglycaemia Awareness Restoration Trial (DAFNE-HART). DIABETIC MEDICINE, Vol. 30 (pp 148-148)
• Elliott J, Kruger J, Jacques R & Heller S (2013) Substantial savings in emergency treatment costs following structured education in patients with Type 1 diabetes. DIABETIC MEDICINE, Vol. 30 (pp 6-7)
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R & Elliott J (2013) The cost-effectiveness of five week vs one week DAFNE structured education in Type 1 diabetes: a preliminary evaluation using the Sheffield Type 1 diabetes policy model. DIABETIC MEDICINE, Vol. 30 (pp 131-131)
• Elliott J, Khalid S, Emery CJ & Heller S (2013) Improvements in both glycaemic control and quality of life following structured education in patients with Type 1 diabetes of Black and minority ethnic origin. DIABETIC MEDICINE, Vol. 30 (pp 7-7)
• Elliott J, Hallsworth J, Sutton M & Tesfaye S (2002) Podiatry-led neuropathy ulcer clinics allow effective management of limited time and resources. DIABETOLOGIA, Vol. 45 (pp A3-A4)
• ELLIOTT J, SMART D, TRAYNOR JR & LAMBERT DG (1993) Characterization of the μ-Opioid Receptors on SH-SY5Y Cells using β-Funaltrexamine (β-FNA) and Naloxonazine. Biochemical Society Transactions, Vol. 21(4) (pp 469S-469S)

Posters

• Basarir H, Kruger J, Brennan A, Thokala P, Jacques R, Dixon S, Elliott J, Heller S & Mansell P The Cost-Effectiveness of 5-week versus 1-week DAFNE Structured Education in Type 1 Diabetes: A Preliminary Evaluation Using the Sheffield Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).

Other

• Elliott J & Heller S (2011) Hypoglycaemia unawareness. Practical Diabetes International, 28(5), 227-232.